Sernova Corp. (TSE:SVA – Get Free Report) shares fell 4.5% during mid-day trading on Friday . The stock traded as low as C$0.21 and last traded at C$0.21. 56,087 shares changed hands during trading, a decline of 64% from the average session volume of 157,444 shares. The stock had previously closed at C$0.22.
Sernova Trading Down 4.5 %
The company has a market capitalization of C$68.32 million, a price-to-earnings ratio of -1.62 and a beta of 1.35. The company has a debt-to-equity ratio of 16.55, a quick ratio of 18.11 and a current ratio of 0.32. The firm has a fifty day moving average price of C$0.23 and a 200-day moving average price of C$0.25.
Sernova Company Profile
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Featured Articles
- Five stocks we like better than Sernova
- Best Stocks Under $5.00
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Best Aerospace Stocks Investing
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Technology Stocks Explained: Here’s What to Know About Tech
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
